UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 2, 2005
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of registrant as specified in charter)
|
Delaware |
|
1-16789 |
|
04-3565120 |
|
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
51 Sawyer Road, Suite 200,
Waltham, Massachusetts 02453
(Address of Principal
Executive Offices) (Zip Code)
(781) 647-3900
(Registrant’s telephone
number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations And Financial Condition.
On November 2, 2005, Inverness Medical Innovations, Inc. (the “Company”) issued a press release entitled “Inverness Medical Innovations Announces Third Quarter 2005 Results,” a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
*99.1 |
|
Press Release dated November 2, 2005, entitled “Inverness Medical Innovations Announces Third Quarter 2005 Results” |
* Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
INVERNESS MEDICAL INNOVATIONS, INC. |
||
|
|
|
||
|
|
|
||
|
Date: November 2, 2005 |
By: |
/s/ Christopher J. Lindop |
|
|
|
|
Christopher J. Lindop |
|
|
|
|
Chief Financial Officer |
|
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
|
|
|
|
*99.1 |
|
Press Release dated November 2, 2005, entitled “Inverness Medical Innovations Announces Third Quarter 2005 Results” |
* Filed herewith.
2